Compare TLYS & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLYS | ECOR |
|---|---|---|
| Founded | 1982 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3M | 50.0M |
| IPO Year | 2011 | 2018 |
| Metric | TLYS | ECOR |
|---|---|---|
| Price | $1.47 | $6.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $2.25 | ★ $22.00 |
| AVG Volume (30 Days) | 37.1K | ★ 47.8K |
| Earning Date | 01-01-0001 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.51 |
| EPS | ★ 0.29 | N/A |
| Revenue | N/A | ★ $25,182,000.00 |
| Revenue This Year | N/A | $28.92 |
| Revenue Next Year | $1.18 | $32.50 |
| P/E Ratio | $5.00 | ★ N/A |
| Revenue Growth | N/A | ★ 57.09 |
| 52 Week Low | $0.57 | $4.16 |
| 52 Week High | $4.22 | $14.01 |
| Indicator | TLYS | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 52.10 |
| Support Level | $1.32 | $4.64 |
| Resistance Level | $2.08 | $7.96 |
| Average True Range (ATR) | 0.09 | 0.77 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 73.81 | 53.60 |
Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.